NPI: 1205824208 · COUSHATTA, LA 71019 · Critical Access Hospital · NPI assigned 10/12/2005
Authorized official WILSON, MONTE controls 20+ related entities in our dataset. Read more
| Authorized Official | WILSON, MONTE (CEO) |
| NPI Enumeration Date | 10/12/2005 |
Other providers sharing the same authorized official: WILSON, MONTE
| Year | Claims | Total Paid |
|---|---|---|
| 2018 | 15,452 | $774K |
| 2019 | 14,919 | $594K |
| 2020 | 8,155 | $292K |
| 2021 | 11,903 | $523K |
| 2022 | 14,189 | $899K |
| 2023 | 16,142 | $1.02M |
| 2024 | 11,749 | $785K |
| Code | Description | Claims | Beneficiaries | Total Paid |
|---|---|---|---|---|
| 99283 | Emergency department visit for the evaluation and management, moderate severity | 8,394 | 7,567 | $2.05M |
| 99284 | Emergency department visit for the evaluation and management, high severity | 3,097 | 2,781 | $1.25M |
| 99285 | Emergency department visit for the evaluation and management, high severity with immediate threat to life | 1,242 | 1,027 | $406K |
| G0378 | Hospital observation service, per hour | 418 | 268 | $210K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 602 | 563 | $104K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | 1,447 | 1,122 | $86K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 13,048 | 9,560 | $74K |
| 80050 | General health panel | 1,691 | 1,595 | $70K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 919 | 811 | $67K |
| 80053 | Comprehensive metabolic panel | 7,832 | 6,532 | $60K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 1,439 | 1,345 | $57K |
| 36415 | Collection of venous blood by venipuncture | 25,492 | 18,816 | $56K |
| 71045 | Radiologic examination, chest; single view | 918 | 736 | $46K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 530 | 492 | $44K |
| 71046 | Radiologic examination, chest; 2 views | 554 | 439 | $39K |
| 96361 | Intravenous infusion, hydration; each additional hour | 30 | 13 | $27K |
| 0240U | 277 | 230 | $26K | |
| J7120 | Ringers lactate infusion, up to 1000 cc | 1,398 | 880 | $22K |
| 80061 | Lipid panel | 1,630 | 1,559 | $19K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3,816 | 868 | $16K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 1,238 | 960 | $14K |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | 37 | 14 | $13K |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 567 | 483 | $12K |
| 83735 | 2,339 | 1,590 | $11K | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | 1,708 | 1,449 | $11K |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | 260 | 188 | $9K |
| 83036 | Hemoglobin; glycosylated (A1C) | 1,069 | 1,003 | $8K |
| 99213 | Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 256 | 223 | $6K |
| 70450 | Computed tomography, head or brain; without contrast material | 34 | 25 | $6K |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | 776 | 633 | $5K |
| 80069 | 860 | 591 | $5K | |
| 84484 | 784 | 565 | $5K | |
| 81003 | 2,799 | 2,398 | $4K | |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | 33 | 13 | $4K |
| 0012A | 154 | 122 | $4K | |
| 84439 | 468 | 424 | $3K | |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 58 | 56 | $3K |
| 81002 | 1,046 | 933 | $3K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 113 | 111 | $3K |
| 0011A | 196 | 125 | $2K | |
| G0379 | Direct admission of patient for hospital observation care | 21 | 15 | $2K |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 45 | 34 | $2K |
| 86328 | 63 | 58 | $2K | |
| 84100 | 450 | 352 | $2K | |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 121 | 106 | $1K |
| 84481 | 128 | 115 | $1K | |
| 82553 | 216 | 158 | $1K | |
| 0064A | 96 | 70 | $1K | |
| J7030 | Infusion, normal saline solution , 1000 cc | 66 | 44 | $1K |
| 87086 | Culture, bacterial; quantitative colony count, urine | 158 | 144 | $965.17 |
| 82550 | 237 | 175 | $773.07 | |
| 0001A | 27 | 23 | $645.50 | |
| 82607 | 51 | 50 | $625.36 | |
| 81025 | 120 | 110 | $620.91 | |
| 83880 | 82 | 65 | $550.03 | |
| 80074 | 15 | 14 | $519.29 | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | 16 | 16 | $484.88 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | 102 | 78 | $419.86 |
| 80305 | 44 | 40 | $418.84 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | 20 | 14 | $406.72 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | 13 | 12 | $350.90 |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | 13 | 12 | $350.90 |
| 82728 | 13 | 12 | $177.87 | |
| 84466 | 13 | 12 | $166.52 | |
| 83540 | 25 | 24 | $149.13 | |
| 83690 | 26 | 25 | $146.09 | |
| 85610 | 44 | 38 | $107.94 | |
| 85730 | 27 | 26 | $102.65 | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 59 | 50 | $72.06 |
| 91301 | 275 | 213 | $5.51 | |
| J0702 | Injection, betamethasone acetate 3 mg and betamethasone sodium phosphate 3 mg | 14 | 14 | $5.05 |
| T1015 | Clinic visit/encounter, all-inclusive | 64 | 57 | $0.00 |
| 91300 | 80 | 61 | $0.00 | |
| 00000 | 30 | 26 | $0.00 | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 21 | 12 | $0.00 |
| 96375 | Therapeutic injection; each additional sequential IV push | 96 | 40 | $0.00 |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 35 | 26 | $0.00 |
| 91306 | 14 | 13 | $0.00 |